Atossa Therapeutics
-$0.12 (-4.39%) As of 7:48 PM UTC today
Why Robinhood?
You can buy or sell ATOS and other stocks, options, and ETFs commission-free!
About ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests.
CEO
Steven C. Quay
Employees
8
Headquarters
Seattle, Washington
Founded
2008
ATOS Key Statistics
Market Cap
299.98M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
17.91M
High Today
$2.78
Low Today
$2.48
Open Price
$2.58
Volume
7.91M
52 Week High
$5.08
52 Week Low
$0.81
ATOS Earnings
-$0.88
-$0.59
-$0.29
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market